Bluejay Diagnostics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Material Modifications to Rights of Security Holders

Regulation FD Disclosure

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus filed under Rule 424(b)(1)

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Wurth Douglas Clark

ZEIDMAN FRED S

Dey Svetlana

CHASE DONALD R

Dey Indranil

ARMISTICE CAPITAL, LLC

Ayrton Capital LLC

BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC.

BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC.

HRT FINANCIAL LP

HRT FINANCIAL LP

BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC.

BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC.

INTRACOASTAL CAPITAL, LLC

NORTHSTRIVE FUND II LP

Braeden Lichti

ZEIDMAN FRED S

CHASE DONALD R

Dey Indranil

Dey Svetlana

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)